Study of Efficacy of OXN PR, Compared to Oxy PR, for Reduction of Intensity of Opioid-induced Constipation Symptoms in patients Treated for Cancer or Non-cancer Pain: A Randomised, Double-blind, Controlled, Multicentre Study.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2015
At a glance
- Drugs Oxycodone; Oxycodone/naloxone
- Indications Back pain; Cancer pain; Constipation; Musculoskeletal pain; Pain
- Focus Therapeutic Use
- 04 Jul 2012 Napp Pharmaceutical Group added as associations as reported in the European Clinical Trials Database record.
- 15 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Jun 2011 Planned end date (May 2012) added as reported by ClinicalTrials.gov.